Neurocrine Biosciences Inc
Veridion Score
Composite trend over time
Why is NBIX moving today?
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for NBIX.
NBIX insider activity
Neurocrine Biosciences Inc
6 insiders bought in the last 90 days
Net selling: -$56.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | 2026-06-05 | SHERWIN STEPHEN A | Insider | sell | $167.31 | 1,843 | 15,860 | $308K | SEC Form 4 |
| 2026-06-09 | 2026-06-05 | SHERWIN STEPHEN A | Insider | sell | $166.56 | 5,829 | 17,703 | $971K | SEC Form 4 |
| 2026-06-09 | 2026-06-05 | SHERWIN STEPHEN A | Insider | sell | $165.79 | 6,896 | 23,532 | $1.1M | SEC Form 4 |
| 2026-06-09 | 2026-06-05 | SHERWIN STEPHEN A | Insider | sell | $164.44 | 2,549 | 30,428 | $419K | SEC Form 4 |
| 2026-06-09 | 2026-06-05 | SHERWIN STEPHEN A | Insider | sell | $163.81 | 7,883 | 32,977 | $1.3M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 62 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moNBIX contract awards, year to date.
Public federal awards linked to this ticker.
NBIX lobbying filings, year to date.
Registered lobbying filings matched to Neurocrine Biosciences Inc.